Thanks to the rapid development of single-cell sequencing experiments and analytical techniques, some studies found that CD4+ conventional T cells-related lncRNAs signature was associated with hepatocellular carcinoma, breast cancer prognosis, therapy, and tumor microenvironment (23, 24). This evidence concerns the gene CD4 and hepatocellular carcinoma.